JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Vermilion Energy
VET
$1.82B
| $452K | ﹤0.01% |
36,301
-4,645
| -11% | -$57.3K |
|
4352
iShares Morningstar Small-Cap Value ETF
ISCV
$692M
| $451K | ﹤0.01% |
8,342
-8,614
| -51% | -$443K |
|
|
DBTX
4353
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $450K | ﹤0.01% |
116,981
-8,680
| -7% | -$31.9K |
|
4354
Nuveen Municipal Credit Income Fund
NZF
$2.4B
| $450K | ﹤0.01% |
+38,558
| New | +$447K |
|
4355
Prime Medicine
PRME
$527M
| $449K | ﹤0.01% |
30,672
+17,775
| +138% | +$248K |
|
4356
Prospect Capital
PSEC
$1.07B
| $447K | ﹤0.01% |
72,077
+44,866
| +165% | +$289K |
|
|
PEO
4357
Adams Natural Resources Fund
PEO
$739M
| $446K | ﹤0.01% |
22,264
+16,866
| +312% | +$331K |
|
4358
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.15B
| $446K | ﹤0.01% |
4,850
-19,231
| -80% | -$1.68M |
|
|
PRTK
4359
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $446K | ﹤0.01% |
201,636
+198,893
| +7,251% | +$412K |
|
4360
Pennant Group
PNTG
$1.4B
| $443K | ﹤0.01% |
36,085
-11,454
| -24% | -$146K |
|
4361
Primis Financial Corp
FRST
$399M
| $443K | ﹤0.01% |
52,607
-10,122
| -16% | -$84.7K |
|
4362
RUM Group Inc
RUM
$1.61B
| $442K | ﹤0.01% |
49,580
+3,758
| +8% | +$35.4K |
|
|
TBCH
4363
Turtle Beach Corp
TBCH
$243M
| $442K | ﹤0.01% |
37,933
+25,969
| +217% | +$290K |
|
|
PPL
4364
CALL
PPL Corp
PPL
$26.5B
| $442K | ﹤0.01% |
16,700
| – | – |
|
4365
1-800-Flowers.com
FLWS
$250M
| $440K | ﹤0.01% |
56,420
-645,424
| -92% | -$5.92M |
|
4366
Great Southern Bancorp
GSBC
$874M
| $439K | ﹤0.01% |
8,662
-1,302
| -13% | -$66.6K |
|
4367
Innovator US Equity Power Buffer ETF November
PNOV
$886M
| $439K | ﹤0.01% |
12,957
+8,601
| +197% | +$279K |
|
|
XYZ
4368
PUT
Block Inc
XYZ
$48.4B
| $439K | ﹤0.01% |
6,600
-60,200
| -90% | -$3.76M |
|
4369
Direxion Daily TSLA Bear 1X ETF
TSLS
$85.8M
| $439K | ﹤0.01% |
2,235
+135
| +6% | +$36.8K |
|
|
MRNS
4370
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $437K | ﹤0.01% |
40,284
+39,536
| +5,286% | +$339K |
|
4371
Amplify CWP Enhanced Dividend Income ETF
DIVO
$7.5B
| $437K | ﹤0.01% |
12,138
-12,089
| -50% | -$429K |
|
|
WBA
4372
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $436K | ﹤0.01% |
15,300
-800
| -5% | -$26.1K |
|
4373
WPP
WPP
$4.36B
| $435K | ﹤0.01% |
8,313
+6,158
| +286% | +$346K |
|
4374
Direxion Daily MSFT Bear 1X ETF
MSFD
$8.33M
| $434K | ﹤0.01% |
25,000
| – | – |
|
4375
CareDx
CDNA
$2.26B
| $434K | ﹤0.01% |
51,049
-178,103
| -78% | -$1.48M |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.